Loading...
Depression worsens the course of dementia, but evidence for the effectiveness of antidepressants in patients with these illnesses is sparse and inconsistent. This large, randomized, controlled, 39-week treatment trial involved 326 patients with possible or probable Alzheimer disease, who were mostly community-dwelling and had sought care for depression at one of nine U.K. “old-age psychiatry services” (Cornell Scale for Depression in Dementia [CSDD] score, ≥8; mean score on the Mini-Mental State Exam, 18).
Treatments were sertraline, mirtazapine, or placebo; doses were increased at 4 and 8 weeks if CSDD scores did not decrease to below 4. Completion rates were 79% at 13 weeks (acute phase) and 69% at 39 weeks (mean doses among completers: se…